Covid-19 vaccines could be authorized for young children by September, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told ProPublica.
“I would think by the time we get to school opening, we likely will be able to get people who come into the first grade,” Fauci said.
Pfizer and Moderna, the two companies currently with authorized Covid-19 vaccines in the US, have both begun trials for children, but started with older age groups.
Pfizer’s trial in children ages 12-15 is fully enrolled with 2,259 participants, and the company says it hopes to have results “in the early part of 2021 and from there, we will plan to finalize our study in 5-11 year olds.”
Moderna is still enrolling participants in its trial in children ages 12-18, though the company says it has seen an increase in enrollment and interest in its trial, adding that “we are on track to provide updated data around mid-year 2021.”
Moderna also has plans to start studying its vaccine on even younger children – 6 months to 11 years old – though the company says it will take longer to get that data.
“We're going to start soon a young children's study, but this will take much longer because we have to age deescalate and start at a lower dose. So we should not anticipate clinical data in 2021, but more in 2022,” said Stéphane Bancel, Chief Executive Officer of Moderna, during an investor presentation last month.